Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.

[1]  C. Kennedy,et al.  Quality of survival assessment in European childhood brain tumour trials, for children aged 5 years and over. , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[2]  H. Dörr,et al.  Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma. , 2014, International journal of radiation oncology, biology, physics.

[3]  A. Gajjar,et al.  Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Björk-Eriksson,et al.  Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  R. Sarin,et al.  Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy. , 2012, International journal of radiation oncology, biology, physics.

[6]  G. Andriole,et al.  Heavy ethanol intake and elevated prostate cancer risk among men with previous negative biopsies in the REDUCE trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Jane Galvin,et al.  Ecological assessment of cognitive functions in children with acquired brain injury: A systematic review , 2011, Brain injury.

[8]  G. Armstrong.  Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. , 2010, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[9]  Alan S. Kaufman,et al.  Kaufman Assessment Battery for Children , 2010 .

[10]  G. Gustafsson,et al.  Health and persistent functional late effects in adult survivors of childhood CNS tumours: a population-based cohort study. , 2009, European journal of cancer.

[11]  H. Brisse,et al.  From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980–2000) , 2009, Journal of Neuro-Oncology.

[12]  D. Figarella-Branger,et al.  Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  C. Urban,et al.  A scoring system to quantify late effects in children after treatment for medulloblastoma/ependymoma and its correlation with quality of life and neurocognitive functioning , 2009, Child's Nervous System.

[14]  M. Schmiegelow.  Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours. , 2006, Danish medical bulletin.

[15]  M. Noseworthy,et al.  Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: correlation with IQ. , 2006, Neuro-oncology.

[16]  E. Boltshauser,et al.  Outcome of Medulloblastoma in Children: Long-Term Complications and Quality of Life , 2005, Neuropediatrics.

[17]  D. Bowers,et al.  Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma , 2005, Journal of Neuro-Oncology.

[18]  Amar Gajjar,et al.  Late neurocognitive sequelae in survivors of brain tumours in childhood. , 2004, The Lancet. Oncology.

[19]  A. Poretti,et al.  Outcome of craniopharyngioma in children: long-term complications and quality of life. , 2004, Developmental medicine and child neurology.

[20]  Eric Bouffet,et al.  Change in neurocognitive functioning after treatment with cranial radiation in childhood. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  T. Merchant,et al.  Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. , 2003, International journal of radiation oncology, biology, physics.

[22]  A. Castellote,et al.  Second malignancies in pediatric patients: imaging findings and differential diagnosis. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[23]  Amar Gajjar,et al.  Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors , 2003, Cancer.

[24]  S. Pigott,et al.  The Relationship Between Parental Report on the BRIEF and Performance-Based Measures of Executive Function in Children with Moderate to Severe Traumatic Brain Injury , 2002, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.

[25]  R. Butler,et al.  Attentional processes and their remediation in children treated for cancer: A literature review and the development of a therapeutic approach , 2002, Journal of the International Neuropsychological Society.

[26]  W E Reddick,et al.  Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  W E Reddick,et al.  Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  C. Sainte-Rose,et al.  Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. , 1999, International journal of radiation oncology, biology, physics.

[29]  Wan Ariffin Bin Abdullah,et al.  Med Pediatr Oncol , 1999 .

[30]  M. Prados,et al.  Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. , 1999, International journal of radiation oncology, biology, physics.

[31]  A. Nirenberg,et al.  Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. , 1996, International journal of radiation oncology, biology, physics.

[32]  A. Ogilvy-Stuart,et al.  Growth and puberty after growth hormone treatment after irradiation for brain tumours. , 1995, Archives of disease in childhood.

[33]  J. Fowler.  Review: total doses in fractionated radiotherapy--implications of new radiobiological data. , 1984, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[34]  S. Palmer.  Neurodevelopmental impact on children treated for medulloblastoma: a review and proposed conceptual model. , 2008, Developmental disabilities research reviews.

[35]  A. Glaser,et al.  Standardized quantitative assessment of brain tumor survivors treated within clinical trials in childhood , 1999, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[36]  J. Pillow,et al.  Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation. , 1989, Medical and pediatric oncology.

[37]  J. Raven,et al.  Manual for Raven's progressive matrices and vocabulary scales , 1962 .